351 related articles for article (PubMed ID: 2441054)
1. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity.
Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J
Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694
[TBL] [Abstract][Full Text] [Related]
5. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
Lignon MF; Galas MC; Rodriguez M; Laur J; Aumelas A; Martinez J
J Biol Chem; 1987 May; 262(15):7226-31. PubMed ID: 2438274
[TBL] [Abstract][Full Text] [Related]
7. A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
Mendre C; Rodriquez M; Gueudet C; Lignon MF; Galas MC; Laur J; Worms P; Martinez J
J Biol Chem; 1988 Aug; 263(22):10641-5. PubMed ID: 3392031
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
9. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
Charpentier B; Durieux C; Menant I; Roques BP
J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
[TBL] [Abstract][Full Text] [Related]
10. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
[TBL] [Abstract][Full Text] [Related]
12. Cyclic cholecystokinin analogues with high selectivity for central receptors.
Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
[TBL] [Abstract][Full Text] [Related]
13. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
Lignon MF; Galas MC; Rodriguez M; Martinez J
Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J
Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470
[TBL] [Abstract][Full Text] [Related]
16. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
[TBL] [Abstract][Full Text] [Related]
17. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180.
Matozaki T; Göke B; Tsunoda Y; Rodriguez M; Martinez J; Williams JA
J Biol Chem; 1990 Apr; 265(11):6247-54. PubMed ID: 1690723
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]